/ Updated December 3rd, 2025

Radiation For Metastatic Prostate Cancer: An Evolving Role

: Dr. Sumit K Subudhi Medical Source: Dr. Neha Vapiwala
University of Pennsylvania Written by: Dr. David Gasalberti

Details
Transcript
Save This Video

Radiation's Role In Treating Advanced Prostate Cancer

Metastatic prostate cancer, or cancer that has spread beyond the prostate, typically requires systemic therapy (which treats the whole body) like hormone therapy. However, radiation can play a critical role in helping to relieve symptoms and prevent further complications.
Patients with metastatic disease that has only spread to a few select spots may benefit from aggressive local or targeted radiation to these disease sites.
“We use a lot of advanced technology to pinpoint, target, and give a high-dose of radiation therapy to a very limited area with the goal of really killing the cancer cells that have spread from the prostate to this other location,” Dr. Neha Vapiwala, professor of radiation oncology at the University of Pennsylvania in Philadelphia, tells SurvivorNet.
New evidence also suggests that treating the prostate gland with radiation — even with metastatic disease — can improve outcomes for some patients.

Metastatic prostate cancer means the disease has spread beyond the prostate, most often to the bones. While this generally requires systemic therapy (or therapy that treats the whole body), radiation can play a crucial role in relieving symptoms, preventing complications, and improving outcomes in selected patients. Patients with oligometastatic disease (a few metastases) may benefit from aggressive local treatment to all metastatic sites.

“When a patient is first diagnosed and found to have some of these metastatic lesions, assuming they are limited in number and depending on the location of the lesions, there can be a role for metastasis-directed radiation therapy, which is given with the goal of ablating the cancer that’s there,” Dr. Neha Vapiwala, professor of radiation oncology at the University of Pennsylvania in Philadelphia, tells SurvivorNet.

“We use a lot of advanced technology to pinpoint, target, and give a high-dose of radiation therapy to a very limited area with the goal of really killing the cancer cells that have spread from the prostate to this other location,” she adds.

Decisions about radiation therapy should be individualized, taking into account disease extent, patient health, and overall treatment goals.

How Is Metastatic Prostate Cancer Treated?

When prostate cancer becomes metastatic, it means that the cancer has spread beyond the prostate gland to other parts of the body. This spread most commonly occurs to the lymph nodes, bones, and in some cases to other organs or soft tissues. Metastatic prostate cancer is considered an advanced disease, and it typically cannot be controlled with localized treatments like surgery or radiation therapy to the prostate alone. Instead, systemic therapies — such as hormone therapy, chemotherapy, radioligand therapy, or a vaccine — are required to manage the disease throughout the body.

However, even though metastatic prostate cancer is widespread, radiation therapy still plays an important role in managing symptoms and, in certain situations, improving survival.

Prostate cancer usually begins as a localized disease confined to the prostate gland. Over time, in some men, cancer cells can escape the prostate and travel through the bloodstream or lymphatic system to other areas. The bones — particularly the spine, pelvis, and ribs — are the most common sites of spread. These secondary tumors in the bones can cause significant complications, including pain, fractures, and decreased mobility.

When this happens, treatment goals shift from curing the cancer to controlling symptoms, slowing disease progression, and maintaining quality of life. That is where radiation therapy often becomes an important part of the care plan.

Managing Symptoms With Radiation

One of the most important roles of radiation therapy in metastatic prostate cancer is palliation — that is, relieving symptoms caused by the spread of the cancer.

Radiation can help with the following symptoms:

Bone pain relief: Bone metastases can be extremely painful, often interfering with daily activities such as walking or sleeping. Radiation therapy directed to these affected bones can significantly reduce pain, sometimes after just one or two treatments.
Preventing fractures: In some cases, bone metastases can weaken the bone so much that it becomes prone to breaking. This is known as a pathologic fracture. Radiation can strengthen the bone by killing tumor cells, which helps prevent fractures.
Spinal cord compression: If a tumor grows near the spine, it can press on the spinal cord, causing pain, weakness, or even paralysis. Radiation therapy in this situation is an emergency treatment to prevent permanent nerve damage.

Palliative radiation is usually well-tolerated and can provide rapid relief, improving a patient’s quality of life dramatically.

Oligometastatic Disease: A Special Category

Not all metastatic prostate cancers behave the same way. Some patients have what is called oligometastatic disease, meaning they have only a limited number of metastatic sites — usually five or less.

Recent clinical trials have shown that patients with oligometastatic disease may benefit from treating all sites of cancer with local therapies like radiation. This approach is sometimes called metastasis-directed therapy (MDT).

It helps by controlling the cancer at each metastatic site and reducing the overall cancer burden, which may delay disease progression and extend survival.

Treatment might involve advanced techniques such as stereotactic body radiation therapy (SBRT), which delivers very high doses of radiation with pinpoint accuracy, minimizing damage to surrounding healthy tissue.

In several studies, this approach has led to substantial improvements in progression-free survival, meaning patients go longer without their cancer worsening. In some cases, it may even allow patients to delay starting more aggressive systemic therapies.

Radiation To The Primary Prostate Tumor

Traditionally, when prostate cancer was already metastatic at diagnosis, doctors focused only on systemic treatment and did not treat the prostate itself. However, new evidence suggests that treating the prostate gland with radiation — even in the setting of metastatic disease — can improve outcomes for some patients.

Patients with a low volume of metastatic disease (generally fewer than five metastatic sites) appear to gain the greatest benefit from this approach.

The primary tumor may continue to seed cancer cells into other parts of the body. By controlling the tumor at its source, the spread may slow down, and patients may live longer.

“We normally did not ever think to treat the prostate, and it was generally felt that that would not be necessary or appropriate because the horse [is] already out of the barn, so to speak,” Dr. Vapiwala explains. “…Now an increasing number of clinical trials have demonstrated very promising data supporting the use of radiation in certain patients to the prostate itself, even though the cancer has spread outside of the prostate.”

Side Effects & Safety Of Radiation

Radiation therapy, even when used for metastatic disease, is generally well tolerated. Most side effects are localized to the treatment area and may include:

Fatigue (usually temporary)
Skin irritation near the treatment site
Mild bowel or bladder symptoms if the pelvis is treated
Bone marrow suppression (in rare cases, if large areas are irradiated)

Because modern techniques like SBRT are highly targeted, the risk of serious complications is low. Your radiation oncologist will carefully plan your treatment to minimize exposure to healthy tissues.